Venture Management
Venture Management, LLC is a private investment office based in Madison, Wisconsin. The firm invests in technology companies with a geographic emphasis on businesses located in Wisconsin or investing in Wisconsin’s economy. It provides capital, business and legal mentorship, and consulting to early-stage and growth-stage companies.
Venture Management
Madison, Wisconsin, United States, North America
Services
Equity and debt financing
Provides capital to technology companies through venture equity investments and debt/convertible bridge financings.
Business and legal mentorship and consulting
Advisory support including business and legal mentorship targeted at start-ups and seed-stage companies.
Equity and debt financing
Provides capital to technology companies through venture equity investments and debt/convertible bridge financings.
Business and legal mentorship and consulting
Advisory support including business and legal mentorship targeted at start-ups and seed-stage companies.
Portfolio
Multiple contracts and government awards; technology milestones include extended neutron-generator runs and commercial facility development. Reported collaborations and contract awards supporting medical isotope and neutron-imaging services.
#Nuclear technology / neutron generators / industrial imaging
Developing M2SR intranasal influenza vaccine; NIH- and DoD-funded clinical trials and human challenge study results reported.
#Biotechnology / vaccines
Commercial orders for OS3 electrolyte material and licensing agreements with Hitachi Chemical; raised $8 million in equity financing with participation by Hitachi Chemical and Inabata (Inabata to serve as an exclusive distributor in parts of Asia).
#Energy storage / lithium-ion battery electrolytes (organosilicon materials)
Platforms for multispecific antibodies; collaborations with Exelixis, Merck and academic partners. Reported financings include more than $3 million raised from multiple investors (filed 2016); business model includes licensing technology to pharmaceutical partners and exploring co-development arrangements.
#Biotechnology / antibody discovery and multispecific biologics
Acquired by Tesoro (transaction reported in 2016).
#Renewable fuels technology / clean-tech
Acquired by Ethicon (Johnson & Johnson) (reported 2016).
#Medical devices / minimally invasive ablation
Multiple contracts and government awards; technology milestones include extended neutron-generator runs and commercial facility development. Reported collaborations and contract awards supporting medical isotope and neutron-imaging services.
#Nuclear technology / neutron generators / industrial imaging
Developing M2SR intranasal influenza vaccine; NIH- and DoD-funded clinical trials and human challenge study results reported.
#Biotechnology / vaccines
Commercial orders for OS3 electrolyte material and licensing agreements with Hitachi Chemical; raised $8 million in equity financing with participation by Hitachi Chemical and Inabata (Inabata to serve as an exclusive distributor in parts of Asia).
#Energy storage / lithium-ion battery electrolytes (organosilicon materials)
Platforms for multispecific antibodies; collaborations with Exelixis, Merck and academic partners. Reported financings include more than $3 million raised from multiple investors (filed 2016); business model includes licensing technology to pharmaceutical partners and exploring co-development arrangements.
#Biotechnology / antibody discovery and multispecific biologics
Acquired by Tesoro (transaction reported in 2016).
#Renewable fuels technology / clean-tech
Acquired by Ethicon (Johnson & Johnson) (reported 2016).
#Medical devices / minimally invasive ablation